Related Experiment Video
Updated: Sep 24, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Pediatric Acute Liver Failure Due to Type 2 Autoimmune Hepatitis Associated With SARS-CoV-2 Infection: A Case Report
Julie Osborn1, Sara Szabo2, Anna L Peters1,3
1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can uncommonly cause pediatric acute liver failure. This case links SARS-CoV-2 to autoimmune hepatitis, successfully treated with steroids.
Area of Science:
- Pediatric Hepatology
- Infectious Diseases
- Immunology
Background:
- Elevated liver enzymes are common in children hospitalized with SARS-CoV-2.
- Pediatric acute liver failure (PALF) is a rare manifestation of COVID-19.
- Autoimmune liver diseases can present with acute liver injury.
Observation:
- A previously healthy 3-year-old girl developed PALF after a mild SARS-CoV-2 infection.
- Viral hepatitis and multisystem inflammatory syndrome in children (MIS-C) were ruled out.
- Liver biopsy revealed acute submassive hepatocyte necrosis with T-cell infiltration.
Findings:
- The patient was diagnosed with type 2 autoimmune hepatitis.
- High-dose methylprednisolone treatment rapidly normalized liver function tests (ALT, AST, INR) and ammonia levels.
- Liver transplantation was successfully avoided.
Implications:
- This case suggests a potential association between SARS-CoV-2 infection and the development of autoimmune hepatitis.
- Early recognition and immunosuppressive therapy may prevent the need for liver transplantation in such cases.
- Further research is warranted to understand the immunopathogenesis linking SARS-CoV-2 and autoimmune liver disease.
Abstract:
Although elevated liver enzymes are common in hospitalized children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, pediatric acute liver failure is an uncommon manifestation of COVID-19 disease. We describe the case of a 3-year-old previously healthy female who developed acute liver failure secondary to type 2 autoimmune hepatitis preceded by mild infection with SARS-CoV-2. Testing for viral hepatitis was negative, and the patient did not meet diagnostic criteria for multisystem inflammatory disease in children (MIS-C). A liver biopsy showed acute submassive hepatocyte necrosis with brisk CD3+ T lymphocyte infiltration and no evidence of fibrosis or chronic liver disease. Treatment with high-dose methylprednisolone resulted in rapid normalization of alanine aminotransferase (ALT), aspartate aminotransferase (AST), international normalized ratio (INR), and ammonia levels, and liver transplantation was avoided. This case highlights a possible association between SARS-CoV-2 infection and subsequent development of autoimmune liver disease presenting with acute liver failure.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Kidney Injury II: Pathophysiology
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Kidney Injury III: Clinical Manifestations
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

